Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Autonoma De AguascalientesfiledCriticalUniv Autonoma De Aguascalientes
Priority to MX2014007027ApriorityCriticalpatent/MX2014007027A/en
Publication of MX2014007027ApublicationCriticalpatent/MX2014007027A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The present invention is related to compositions useful for treating diseases associated to an elevated response to pro-inflammatory and factor NF-kB cytokines. Said compositions comprise the leuprolide acetate and at least a pharmaceutically acceptable carrier and/or a pharmaceutically acceptable excipient thereof.
MX2014007027A2014-06-122014-06-12Use of leuprolide acetate as a modulator of proinflammatory and factor nk-kb cytokines.
MX2014007027A
(en)
Compounds derived from 2-8-5-chloropyrimidin-2-ylamino-6,7,8,9-tetrahydro-5h-pyrido3,2-bindol-5-ylacetic acid, modulators of the prostaglandin d2 receptor pharmaceutical composition and its use for the treatment of diseases allergic immune disorders.